These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1329741)

  • 1. Organ distribution and characterization of porcine peptides (VIP, CGRP and PHI) that increase cAMP in rat platelets.
    Ichiki Y; Kitamura K; Kangawa K; Kawamoto M; Matsuo H; Eto T
    Biochem Biophys Res Commun; 1992 Sep; 187(3):1587-93. PubMed ID: 1329741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receptors for VIP and PACAP in guinea pig cerebral cortex: effects on cyclic AMP synthesis and characterization by 125I-VIP binding.
    Zawilska JB; Dejda A; Niewiadomski P; Gozes I; Nowak JZ
    J Mol Neurosci; 2005; 25(3):215-24. PubMed ID: 15800375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dimeric form of calcitonin gene-related peptide in the porcine thyroid gland.
    Ichiki Y; Kitamura K; Kangawa K; Eto T
    Biochem Biophys Res Commun; 1993 Mar; 191(3):961-7. PubMed ID: 8385457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclic AMP formation in chicken brain: effect of vasoactive intestinal peptide, peptide histidine-isoleucine (PHI), and some PHI-related peptides.
    Dejda A; Matczak I; Wiktorowska-Owczarek A; Nowak JZ
    Pol J Pharmacol; 2003; 55(5):747-51. PubMed ID: 14704471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The distribution and chromatographic characterization of PHI (peptide histidine isoleucine amide)-27-like peptides in rat and porcine brain.
    Beinfeld MC; Korchak DM; Roth BL; O'Donohue TL
    J Neurosci; 1984 Nov; 4(11):2681-8. PubMed ID: 6548767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and characterization of peptides which act on rat platelets, from a pheochromocytoma.
    Kitamura K; Kangawa K; Kawamoto M; Ichiki Y; Matsuo H; Eto T
    Biochem Biophys Res Commun; 1992 May; 185(1):134-41. PubMed ID: 1318039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PACAP-38 but not VIP induces release of CGRP from trigeminal nucleus caudalis via a receptor distinct from the PAC1 receptor.
    Jansen-Olesen I; Baun M; Amrutkar DV; Ramachandran R; Christophersen DV; Olesen J
    Neuropeptides; 2014 Apr; 48(2):53-64. PubMed ID: 24508136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
    Zawilska JB; Niewiadomski P; Nowak JZ
    Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newly-identified receptors for peptide histidine-isoleucine and GHRH-like peptide in zebrafish help to elucidate the mammalian secretin superfamily.
    Wu S; Roch GJ; Cervini LA; Rivier JE; Sherwood NM
    J Mol Endocrinol; 2008 Nov; 41(5):343-66. PubMed ID: 18757498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a potential receptor for both peptide histidine isoleucine and peptide histidine valine.
    Tse DL; Pang RT; Wong AO; Chan SM; Vaudry H; Chow BK
    Endocrinology; 2002 Apr; 143(4):1327-36. PubMed ID: 11897689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PACAP, VIP, and PHI: effects on AC-, PLC-, and PLD-driven signaling systems in the primary glial cell cultures.
    Dejda A; Jozwiak-Bebenista M; Nowak JZ
    Ann N Y Acad Sci; 2006 Jul; 1070():220-5. PubMed ID: 16888170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in the goose cerebral cortex.
    Zawilska JB; Niewiadomski P; Nowak JZ
    Pol J Pharmacol; 2004; 56(2):203-11. PubMed ID: 15156071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
    Alexandre D; Anouar Y; Jegou S; Fournier A; Vaudry H
    Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activating peptide receptor subtypes in mouse calvarial osteoblasts: presence of VIP-2 receptors and differentiation-induced expression of VIP-1 receptors.
    Lundberg P; Lundgren I; Mukohyama H; Lehenkari PP; Horton MA; Lerner UH
    Endocrinology; 2001 Jan; 142(1):339-47. PubMed ID: 11145597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of neuropeptides of the secretin/VIP/PACAP family on cyclic AMP formation in the chick hypothalamus and cerebral cortex.
    Nowak JZ; Kuba K; Zawilska JB
    Pol J Pharmacol; 2000; 52(6):467-71. PubMed ID: 11334241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that vascular actions of PHI are mediated by a VIP-preferring receptor.
    Huang M; Itoh H; Lederis K; Rorstad O
    Peptides; 1989; 10(5):993-1001. PubMed ID: 2558369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VPAC2 receptors mediate vasoactive intestinal peptide-induced neuroprotection against neonatal excitotoxic brain lesions in mice.
    Rangon CM; Goursaud S; Medja F; Lelièvre V; Mounien L; Husson I; Brabet P; Jégou S; Janet T; Gressens P
    J Pharmacol Exp Ther; 2005 Aug; 314(2):745-52. PubMed ID: 15872042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclic AMP-dependent protein kinase in Molt 4b lymphoblasts: identification by photoaffinity labeling and activation in intact cells by vasoactive intestinal polypeptide (VIP) and peptide histidine isoleucine (PHI).
    O'Dorisio MS; Wood CL; Wenger GD; Vassalo LM
    J Immunol; 1985 Jun; 134(6):4078-86. PubMed ID: 2985703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the rat proopiomelanocortin gene expression in AtT-20 cells. II: Effects of the pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide.
    Aoki Y; Iwasaki Y; Katahira M; Oiso Y; Saito H
    Endocrinology; 1997 May; 138(5):1930-4. PubMed ID: 9112389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) stimulate interleukin-6 production through the third subtype of PACAP/VIP receptor in rat bone marrow-derived stromal cells.
    Cai Y; Xin X; Shim GJ; Mokuno Y; Uehara H; Yamada T; Agui T; Matsumoto K
    Endocrinology; 1997 Jun; 138(6):2515-20. PubMed ID: 9165043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.